Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > Shorts are winning the war!
View:
Post by shooter300 on Feb 08, 2018 6:31pm

Shorts are winning the war!

Comparing to other mj stocks, shorts are 32% of trades with a large amount of volume., this is a large about of shorts attacking this stock. LOL no wonder why its down so much. 

https://shortdata.ca/?c=emblem-corp.-short-sales&sym=EMC.V
Comment by christophwaltz on Feb 08, 2018 7:00pm
Are you a retired?  Emblem 32% Canopy 31.6% 23% Aurora 24% Emerald 30% Organigram 29% Namaste 25% Cannabis Wheaton 43%   Short data on the weed stocks has been oversized since the getgo. This is just noise. A red herring.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities